Endothelial function and white matter hyperintensities in older adults with cardiovascular disease

Stroke

Volumn 38, Issue 2, 2007, Pages 308-312

  Hoth, Karin F ^a,h   Tate, David F ^a   Poppas, Athena ^a   Forman, Daniel E ^b,c   Gunstad, John ^d   Moser, David J ^e   Paul, Robert H ^f   Jefferson, Angela L ^g   Haley, Andreana P ^a   Cohen, Ronald A ^a  

^a BROWN UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d KENT STATE UNIVERSITY   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Brown University Centers for Behavioral and Preventive Medicine   (United States)

Author keywords

Cardiovascular disease; Endothelium; Magnetic resonance; White matter disease

Indexed keywords

ADULT; AGED; ARTICLE; BRACHIAL ARTERY; BRAIN SIZE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VASODILATATION; WHITE MATTER;

AGED; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; VASODILATION;

EID: 33846634187     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000254517.04275.3f     Document Type: Article

References (40)

1. Almkvist O, Wahlund LO, Andersson-Lundman G, Basun H, Backman L. White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol. 1992;49:626-632.
2. Soderlund H, Nyberg L, Adolfsson R, Nilsson LG, Launer LJ. High prevalence of white matter hyperintensities in normal aging: relation to blood pressure and cognition. Cortex. 2003;39:1093-1105.
3. Gunning-Dixon FM, Raz N. Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study. Neuropsychologia. 2003;41:1929-1941.
4. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol. 2001;58:643-647.
5. Paul RH, Haque O, Gunstad J, Tate DF, Grieve SM, Hoth K, Brickman AM, Cohen R, Lange K, Jefferson AL, MacGregor KL, Gordon E. Subcortical hyperintensities impact cognitive function among a select subset of healthy elderly. Arch Clin Neuropsychol. 2005;20:697-704.
6. Briley DP, Haroon S, Sergent SM, Thomas S. Does leukoaraiosis predict morbidity and mortality? [see comment]. Neurology. 2000;54:90 -94.
7. Benson RR, Guttmann CR, Wei X, Warfield SK, Hall C, Schmidt JA, Kikinis R, Wolfson LI. Older people with impaired mobility have specific loci of periventricular abnormality on MRI.[see comment]. Neurology. 2002;58:48 -55.
8. Yamauchi H, Fukuda H, Oyanagi C. Significance of white matter high intensity lesions as a predictor of stroke from arteriolosclerosis.[see comment]. J Neurol Neurosurg Psych. 2002;72:576-582.
9. Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D'Agostino RB, DeCarli C. Stroke risk profile predicts white matter hyperintensity volume: The Framingham Study. Stroke. 2004;35:1857-1861.
10. Bakker SLM, de Leeuw F-E, de Groot JC, Hofman A, Koudstaal PJ, Breteler MMB. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology. 1999;52:578-583.
11. Isaka Y, Okamoto M, Ashida K, Imaizumi M. Decreased cerebrovascular dilatory capacity in subjects with asymptomatic periventricular hyperintensities. Stroke. 1994;25:375-381.
12. Faraci FM, Heistad DD. Regulation of the cerebral circulation: Role of endothelium and potassium channels. Physiological Reviews. 1998;78:53-97.
13. Joannides R, Haefeli W, Linder L, Richard V, Bakkali E, Thuillez C, Luscher T. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91:1314-1319.
14. Bonvento G, Seylaz J, Lacombe P. Widespread attenuation of the cerebrovascular reactivity to hypercapnia following inhibition of nitric oxide synthase in the conscious rat. J Cerebral Blood Flow Metab. 1994;14:699-703.
15. Iadecola C, Zhang F. Nitric oxide-dependent and -independent components of cerebrovasodilation elicited by hypercapnia. Am J Physiol. 1994;266:R546-552.
16. Thompson BG, Pluta RM, Girton ME, Oldfield EH. Nitric oxide mediation of chemoregulation but not autoregulation of cerebral blood flow in primates. J Neurosurg. 1996;84:71-78.
17. Wang Q, Pelligrino DA, Paulson OB, Lassen NA. Comparison of the effects of ng-nitro-l-arginine and indomethacin on the hypercapnic cerebral blood flow increase in rats. Brain Res. 1994;641:257-264.
18. Wang Q, Pelligrino DA, Baughman VL, Koenig HM, Albrecht RF. The role of neuronal nitric oxide synthase in regulation of cerebral blood flow in normocapnia and hypercapnia in rats. J Cerebral Blood Flow Metab. 1995;15:774-778.
19. Goadsby PJ. Nitric oxide is not the sole determinant of hypercapnic or metabolically driven vasodilation in the cerebral circulation. J Autonomic Nervous System. 1994;49(Suppl):S67-S72.
20. McPherson RW, Kirsch JR, Ghaly RF, Traystman RJ. Effect of nitric oxide synthase inhibition on the cerebral vascular response to hypercapnia in primates. Stroke. 1995;26:682-687.
21. Aldasoro M, Martinez C, Vila JM, Medina P, Lluch S. Influence of endothelial nitric oxide on adrenergic contractile responses of human cerebral arteries. J Cerebral Blood FlowMetab. 1996;16:623-628.
22. Toda N. Mediation by nitric oxide of neurally-induced human cerebral artery relaxation. Experientia. 1993;49:51-53.
23. White RP, Deane C, Vallance P, Markus HS. Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia. Stroke. 1998;29:467-472.
24. White RP, Vallance P, Markus HS. Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans. Clinical Science. 2000;99:555-560.
25. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468-1474.
26. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468-1474.
27. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R. International Brachial Artery Reactivity Task F. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force.[erratum appears in J Am Coll Cardiol 2002;39:1082]. J Am Coll Cardiol. 2002;39:257-265.
28. Kathiresan S, Gona P, Larson MG, Vita JA, Mitchell GF, Tofler GH, Levy D, Newton-Cheh C, Wang TJ, Benjamin EJ, Vasan RS. Crosssectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function. Circulation. 2006;113:938-945.
29. Green D Point: Flow-mediated dilation does reflect nitric oxide-mediated endothelial function.[see comment]. J Appl Physiol. 2005;99:1233-1234, discussion 1237-1238.
30. Pyke KE, Tschakovsky ME. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol. 2005;568:357-369.
31. Vita JA, Keaney JF Jr. Endothelial function: A barometer for cardiovascular risk?[comment]. Circulation. 2002;106:640-642.
32. Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease.[see comment]. Circulation. 2003;108:2054-2059.
33. 2 vasoreactivity- association with endothelial dysfunction. Am J Physiol. 2006;291:H1856-H1861.
34. Folstein MF, Folstein SE. "Mini Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psych Res. 1975;12:189-198.
35. Gunstad J, Cohen R, Tate D, Paul R, Poppas A, Hoth K, Macgregor K, Jefferson A. Blood pressure variability and white matter hyperintensities in older adults with cardiovascular disease. Blood Pressure. 2005;14:353-358.
36. Chimowitz MI, Awad IA, Furlan AJ. Periventricular lesions on MRI. Facts and theories. Stroke. 1989;20:963-967.
37. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683-1689.
38. Moser DJ, Hoth KF, Robinson RG, Paulsen JS, Sinkey CA, Benjamin ML, Schultz SK, Haynes WG. Blood vessel function and cognition in elderly patients with atherosclerosis. Stroke. 2004;35:e369-e372.
39. Bowler JV, Steenhuis R, Hachinski V. Conceptual background to vascular cognitive impairment. Alzheimer Dis Assoc Dis. 1999;13(Suppl 3):S30-S37.
40. Rockwood K. Vascular cognitive impairment and vascular dementia. J Neurol Sci. 2002;203-204:23-27.